Loading...
Loading...
Browse all stories on DeepNewz
VisitOutcome of Roche vs. Stanford and Foresight lawsuit by end of 2024?
Roche wins • 25%
Stanford and Foresight win • 25%
Settlement reached • 25%
Case dismissed • 25%
Court records, official statements from Roche, Stanford, or Foresight Diagnostics
Roche Sues Stanford, Foresight Over Genetic-Sequencing Trade Secrets in Cancer-Detection
Jul 4, 2024, 12:00 AM
Roche has filed a lawsuit against Stanford University and Foresight Diagnostics in California federal court, alleging that Foresight misused its genetic-sequencing trade secrets to develop competing cancer-detection products. Roche is seeking to force Foresight to hand over patent applications related to the disputed technology. This legal action underscores the competitive nature of the cancer-detection market and the importance of genetic-sequencing trade secrets in developing advanced diagnostic tools.
View original story
No action taken • 33%
Lawsuit filed • 33%
Settlement reached • 33%
Nintendo and The Pokémon Company win • 25%
Pocketpair Inc. wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
In Favor of Screening • 25%
Against Screening • 25%
Settlement Reached • 25%
Case Dismissed • 25%
Uncharted Labs wins • 25%
Uncharted Labs loses • 25%
Settlement reached • 25%
Case ongoing • 25%
Vertex wins • 25%
US government wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Cassava Sciences wins the lawsuits • 25%
Cassava Sciences settles the lawsuits • 25%
Cassava Sciences loses the lawsuits • 25%
Lawsuits are dismissed • 25%
Nintendo • 25%
The Pokémon Company • 25%
Pocketpair Inc. • 25%
None of the above • 25%
Settled • 25%
Dismissed • 25%
Ruled in favor of developers • 25%
Ongoing • 25%
Plaintiffs win • 25%
OpenAI wins • 25%
OpenAI settles • 25%
Case dismissed • 25%
Lacks' family wins • 25%
Novartis wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Settled • 25%
Dismissed • 25%
Won by plaintiffs • 25%
Won by CrowdStrike • 25%
Market share increases • 25%
Foresight exits cancer-detection market • 25%
Market share decreases • 25%
Market share remains the same • 25%